Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients-Reference-Cited by-同舟云学术

Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients

Published:2016-10-26 Issue:11 Volume:22 Page:1536-1543
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Kwok Ryan M.¹,Ahn Joseph²,Schiano Thomas D.³,Te Helen S.⁴,Potosky Darryn R.⁵,Tierney Amber⁶,Satoskar Rohit¹,Robertazzi Suzanne¹,Rodigas Colleen¹,Lee Sang Michelle¹,Wiegel Joshua²,Patel Neal³,Gripshover Janet⁵,Hassan Mohamed A.⁶,Branch Andrea³,Smith Coleman I.¹

Affiliation:

1. Medstar Georgetown Transplant Institute; Georgetown University School of Medicine; Washington DC

2. Oregon Health and Science University; Portland OR

3. Division of Liver Diseases and Recanati-Miller Transplant Institute; Mount Sinai Medical Center; New York NY

4. Center for Liver Diseases, Department of Medicine; The University of Chicago Medical Center; Chicago IL

5. Division of Gastroenterology and Hepatology, Department of Medicine; University of Maryland School of Medicine; Baltimore MD

6. University of Minnesota Medical School; Minneapolis MN

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference15 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation;Berenguer;Hepatology,2000

3. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

4. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin;Perrakis;Transplant Proc,2011

5. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis;Wang;Am J Transplant,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

2. Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study;American Journal of Transplantation;2023-10

3. Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study;The Korean Journal of Internal Medicine;2022-11-01

4. The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients;Clinics in Liver Disease;2022-05

5. Occult HCV infection in liver transplanted patients: frequency and consequences;Clinical and Experimental Hepatology;2022